ALYSSA CIANCIO: Open Payments
NPI 1962018259 · ORCHARD PARK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,028 in 180 payments from 26 companies in 2025. Trend: 2023 $3,163 · 2024 $3,555 · 2025 $4,028
Food & beverage: $4,028
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 22 | $537 |
| AstraZeneca Pharmaceuticals LP | 13 | $353 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 14 | $302 |
| Novo Nordisk Inc | 14 | $297 |
| Phathom Pharmaceuticals, Inc. | 8 | $289 |
| Exact Sciences Corporation | 9 | $272 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $225 |
| PFIZER INC. | 11 | $209 |
| GlaxoSmithKline, LLC. | 9 | $201 |
| Lilly USA, LLC | 13 | $179 |
Products named: XIFAXAN, JARDIANCE, VOQUEZNA, AIRSUPRA, Cologuard Collection Kit, Kerendia, TRELEGY ELLIPTA, CAPLYTA.
Industry payments across NY — which companies pay providers there.
